{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:51:53Z","timestamp":1777632713500,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.hlc.2021.04.009","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T11:33:18Z","timestamp":1620300798000},"page":"939-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Why Are We Forgetting Patients With Peripheral Arterial Disease?"],"prefix":"10.1016","volume":"30","author":[{"given":"Jennifer Y.","family":"Barraclough","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma A.","family":"Figtree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Arnott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.hlc.2021.04.009_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.hlc.2020.12.018","article-title":"Inclusion of people with peripheral artery disease in cardiac rehabilitation programs: a pan-Canadian survey","volume":"30","author":"Ahden","year":"2021","journal-title":"Heart Lung Circ"},{"issue":"2","key":"10.1016\/j.hlc.2021.04.009_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/153100350501700220","article-title":"The vascular surgeon's role in risk factor modification: results of a survey","volume":"17","author":"Leon","year":"2005","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"issue":"5","key":"10.1016\/j.hlc.2021.04.009_bib3","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jvs.2019.08.238","article-title":"National assessment of availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication","volume":"71","author":"Dua","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"issue":"4","key":"10.1016\/j.hlc.2021.04.009_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.hlc.2017.10.014","article-title":"Peripheral arterial disease","volume":"27","author":"Conte","year":"2018","journal-title":"Heart Lung Circ"},{"issue":"9","key":"10.1016\/j.hlc.2021.04.009_bib5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.hlc.2021.04.009_bib6","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1161\/01.CIR.94.11.3026","article-title":"Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review","volume":"94","author":"Weitz","year":"1996","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hlc.2021.04.009_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hlc.2021.04.009_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"issue":"41","key":"10.1016\/j.hlc.2021.04.009_bib9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hlc.2021.04.009_bib10","doi-asserted-by":"crossref","first-page":"e012541","DOI":"10.1161\/JAHA.119.012541","article-title":"Adherence to Guideline Recommended Therapy\u2014Including supervised exercise therapy referral\u2014Across peripheral artery disease specialty clinics: Insights from the International PORTRAIT Registry","volume":"9","author":"Saxon","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.hlc.2021.04.009_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hlc.2021.04.009_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jvs.2006.04.002","article-title":"Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study","volume":"44","author":"Blacher","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"issue":"2","key":"10.1016\/j.hlc.2021.04.009_bib13","first-page":"CD000990","article-title":"Exercise for intermittent claudication","author":"Leng","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.hlc.2021.04.009_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2011.04.024","article-title":"A\u00a0systematic review of randomized controlled trials: walking versus alternative exercise prescription as treatment for intermittent claudication","volume":"218","author":"Parmenter","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.hlc.2021.04.009_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jsams.2013.10.251","article-title":"Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication","volume":"17","author":"Askew","year":"2014","journal-title":"J\u00a0Sci Med Sport"},{"issue":"1","key":"10.1016\/j.hlc.2021.04.009_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.111.075770","article-title":"Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study","volume":"125","author":"Murphy","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2021.04.009_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2019.02.070","article-title":"Cardiac rehabilitation in people with peripheral arterial disease: A higher risk population that benefits from completion","volume":"285","author":"Devrome","year":"2019","journal-title":"Int J Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.hlc.2021.04.009_bib18","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","author":"Board","year":"2014","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.hlc.2021.04.009_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.hlc.2020.02.014","article-title":"Cardiac rRehabilitation quality in Australia: proposed National Indicators for Field-Testing","volume":"29","author":"Gallagher","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"9","key":"10.1016\/j.hlc.2021.04.009_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.hlc.2021.04.009_bib21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hlc.2021.04.009_bib22","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1161\/STROKEAHA.118.022922","article-title":"Prescription of pharmacotherapy and the incidence of stroke in patients with symptoms of peripheral artery disease","volume":"49","author":"Nastasi","year":"2018","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.hlc.2021.04.009_bib23","first-page":"78","article-title":"Supervised exercise training for symptomatic peripheral artery disease","volume":"6","author":"Ehrman","year":"2017","journal-title":"J\u00a0Clin Ex Physiol"},{"key":"10.1016\/j.hlc.2021.04.009_bib24","first-page":"CD005263","article-title":"Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication","volume":"2","author":"Bendermacher","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.hlc.2021.04.009_bib25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jvs.2010.02.022","article-title":"Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication","volume":"52","author":"Nicola\u00ef","year":"2010","journal-title":"J\u00a0Vasc sSurg"},{"issue":"4","key":"10.1016\/j.hlc.2021.04.009_bib26","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/CIR.0000000000000623","article-title":"Optimal exercise programs for patients with peripheral artery disease: A Scientific Statement From the American Heart Association","volume":"139","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2021.04.009_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrcardio.2009.223","article-title":"Effects of cardiac rehabilitation referral strategies on referral and enrollment rates","volume":"7","author":"Gravely-Witte","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.hlc.2021.04.009_bib28","first-page":"8","article-title":"The Australian Cardiovascular Alliance (ACvA)","volume":"42","author":"Figtree","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hlc.2021.04.009_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.hlc.2018.12.002","article-title":"The Australian Cardiovascular Alliance-Towards an integrated whole-of-nation strategy to address our major health burden","volume":"28","author":"Figtree","year":"2019","journal-title":"Heart Lung Circ"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950621004182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950621004182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:03:51Z","timestamp":1761415431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950621004182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1443950621004182"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2021.04.009","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why Are We Forgetting Patients With Peripheral Arterial Disease?","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2020.12.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}